1. A phase I study of immunotherapy with GSC‐loaded dendritic cells in patients with recurrent glioblastoma—Full text view—ClinicalTrials.gov. (n.d.). Retrieved fromhttps://clinicaltrials.gov/ct2/show/NCT02820584
2. A study of Ad‐RTS‐hIL‐12 with veledimex in combination with nivolumab in subjects with glioblastoma; a substudy to ATI001‐102—Full text view—ClinicalTrials.gov. (n.d.). Retrieved fromhttps://clinicaltrials.gov/ct2/show/NCT03636477
3. A study of BLZ945 single agent or BLZ945 in combination with PDR001 in advanced solid tumors—Full text view—ClinicalTrials.gov. (n.d.). Retrieved fromhttps://clinicaltrials.gov/ct2/show/NCT02829723
4. A study of fotemustine (FTM) Vs FTM and ipilimumab (IPI) or IPI and nivolumab in melanoma brain metastasis—Full text view—ClinicalTrials.gov. (n.d.). Retrieved fromhttps://clinicaltrials.gov/ct2/show/NCT02460068
5. A study of ICT‐121 dendritic cell vaccine in recurrent glioblastoma—Full text view—ClinicalTrials.gov. (n.d.). Retrieved fromhttps://clinicaltrials.gov/ct2/show/NCT02049489